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Identification of an IL-17–producing
NK1.1neg iNKT cell population involved
in airway neutrophilia
Marie-Laure Michel,1 Alexandre Castro Keller,1 Christophe Paget,2,3
Masakazu Fujio,4,5 François Trottein,2,3 Paul B. Savage,6
Chi-Huey Wong,4,5 Elke Schneider,1 Michel Dy,1
and Maria C. Leite-de-Moraes1
1Unité

Invariant natural killer T (iNKT) cells are an important source of both T helper type 1 (Th1)
and Th2 cytokines, through which they can exert beneficial, as well as deleterious, effects
in a variety of inflammatory diseases. This functional heterogeneity raises the question of
how far phenotypically distinct subpopulations are responsible for such contrasting activities. In this study, we identify a particular set of iNKT cells that lack the NK1.1 marker
(NK1.1neg) and secrete high amounts of interleukin (IL)-17 and low levels of interferon
(IFN)-𝛄 and IL-4. NK1.1neg iNKT cells produce IL-17 upon synthetic (𝛂-galactosylceramide
[𝛂-GalCer] or PBS-57), as well as natural (lipopolysaccharides or glycolipids derived from
Sphingomonas wittichii and Borrelia burgdorferi), ligand stimulation. NK1.1neg iNKT cells
are more frequent in the lung, which is consistent with a role in the natural immunity to
inhaled antigens. Indeed, airway neutrophilia induced by 𝛂-GalCer or lipopolysaccharide
instillation was significantly reduced in iNKT-cell–deficient J𝛂18−/− mice, which produced
significantly less IL-17 in their bronchoalveolar lavage fluid than wild-type controls.
Furthermore, airway neutrophilia was abolished by a single treatment with neutralizing
monoclonal antibody against IL-17 before 𝛂-GalCer administration. Collectively, our findings
reveal that NK1.1neg iNKT lymphocytes represent a new population of IL-17–producing cells
that can contribute to neutrophil recruitment through preferential IL-17 secretion.

CORRESPONDENCE
Maria C. Leite-de-Moraes:
leite.de.moraes@necker.fr

Invariant natural killer T (iNKT) cells constitute
a distinctive population of mature T lymphocytes
that coexpress a highly restricted TCR repertoire composed of a single invariant Vα14Jα18
chain in mice and a Vα24Jα18 chain in humans, preferentially paired with limited TCR
Vβ chains (1–4). This semiinvariant TCR reflects a positive selection by glycolipid antigens
presented by the nonpolymorphic MHC class
I–like molecule CD1d (5). iNKT cells are well
known for their prompt production of cytokines, such as IL-4, IFN-γ, TNF-α, IL-3, and
GM-CSF, in response to the exogenous CD1dbound glycolipid α-galactosylceramide (α-GalCer), the most commonly used stimulant, which
was originally isolated from a marine sponge
(2, 4–8). Recently, more physiological ligands
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have also been identified, i.e., the endogenous
lysosomal glycosphingolipid isoglobotrihexosylceramide (iGb3), exogenous glycosylceramides
from the cell wall of Sphingomonas wittichii,
and diacylglycerol antigens from pathogenic
bacteria (9–12).
Because of their large cytokine spectrum,
iNKT cells can interact with a variety of cells
from the innate immune system and, consequently, affect the outcome of many inflammatory responses against pathogens (8, 13–15). In
this line of evidence, it has been reported that
they provide an early host protection against
Streptococcus pneumonia by promoting the trafficking of neutrophils into airways (16). Moreover, we have previously demonstrated that a
single injection of α-GalCer induces mobilization
Cite by DOI: 10.1084/jem.20061551
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RESULTS AND DISCUSSION
𝛂-GalCer stimulation induces IL-17 production
iNKT cells are plausible candidates for IL-17 production
(20–24), considering that their biological activities overlap
with most of those ascribed to this proinflammatory mediator.
We tested this hypothesis using mononuclear cells (MNCs)
isolated from the liver, where iNKT cells are more abundant
than in other organs, and compared IL-17 production by
total hepatic MNCs from wild-type C57BL/6 and iNKT
cell-deficient (Jα18−/−) mice in response to the iNKT cell–
specific antigen ligand α-GalCer. As shown in Fig. 1 A,
IL-17 was easily detected in cell supernatants from wildtype mice and accumulated during the 72-h incubation
period. In contrast, it failed to be produced by MNCs from
Jα18−/− or from CD1d−/− mice (Fig. 1 A), which are both
iNKT-cell deficient.
We further addressed the question of whether the capacity to induce IL-17 production was shared by more physiological ligands of iNKT cells, such as glycosphingolipids from
Sphingomonas sp and diacylglycerol antigens from B. burgdorferi,
which causes Lyme disease (11, 12). We found that liver cells
from wild-type, but not from Jα18−/−, mice produced IL-17
in response to the galacturonic acid–containing S. wittichii
glycosphingolipid (GalA-GSL) and, to a lesser extent, to
some synthetic variants of BbGLII from B. burgdorferi (Fig.
1 C). Our results concord with previous studies identifying
BbGLIIc as the best BbGLII variant for iNKT cell activation
(12) and prove that ligands with more physiological relevance
than α-GalCer can also induce IL-17 production.
It has been widely documented that iNKT cells produce
large amounts of both IFN-γ and IL-4 in response to α-GalCer
(1–4). Knowing that both cytokines are potent inhibitors of
IL-17 production (22, 23), we examined how this activity
2 of 7

Figure 1. iNKT cell ligands induce IL-17 production by liver
MNCs. Liver MNCs from wild-type, Jα18−/−, and CD1d−/− mice were
stimulated in vitro by α-GalCer (A) or synthetic B. burgdorferi glycolipids
(BbGL-II [IIa–IIh]) or GalA-GSL (GSL) (C). (B) Liver MNCs from wild-type
(WT) or IFN-γ−/− mice were stimulated with α-GalCer in the presence or
absence of anti–IL-4 mAb. In all experiments, IL-17 levels were measured
in supernatants. The addition of isotype controls did not modify IL-17
production by α-GalCer–stimulated liver MNCs and no cytokine were
detected without ligand stimulation (not depicted). Data represent the
mean ± the SD of two to seven individual mice. *, P < 0.05; **, P < 0.01;
***, P < 0.001.

was affected when endogenous IFN-γ and/or IL-4 production was abolished in genetically modified IFN-γ−/− mice
and/or in the presence of neutralizing anti–IL-4 mAbs. The
lack of either cytokine resulted in a clear increase of IL-17
secretion after α-GalCer activation (Fig. 1 B), which was further enhanced in the absence of both, indicating that IL-4
and IFN-γ are produced endogenously and contribute similarly to the inhibition.
The iNKT NK1.1neg subset is the major source of IL-17 after
𝛂-GalCer stimulation
It is well established that α-GalCer acts specifically on iNKT
cells (5). However, other cells could be secondarily stimulated
and potentially produce IL-17 in our experimental model. To
confirm the direct involvement of iNKT cells in IL-17 production, we gated the tetramer CD1d/α-GalCer+ population
NK1.1NEG INKT CELLS PRODUCE INTERLEUKIN-17 | Michel et al.
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of myeloid progenitors (CFU cells) and neutrophils from the
bone marrow to the periphery (8). Yet, it is still not clear
how iNKT cells promote neutrophil recruitment to inflammatory sites and what mediators are involved.
The newly described cytokine IL-17 is a likely candidate
for this task because it has already been implicated in airway
neutrophilia induced by endotoxin exposure (17, 18). Furthermore, it has been documented that in IL-17 receptor–
deficient mice, the host defense against lung bacterial
infection is impaired (19).
Based in these data, we set out to examine whether stimulated iNKT cells were able to produce IL-17, and whether
this cytokine mediated the neutrophil recruitment. We found
that a small subset of iNKT cells lacking the NK1.1 marker
generated high amounts of IL-17, together with low IL-4
and IFN-γ levels, in response to several iNKT cell ligands,
namely, α-GalCer or its analogue PBS-57, as well as glycolipids derived from S. wittichii and Borrelia burgdorferi. This
NK1.1neg iNKT cell subset was more frequent among lung
iNKT cells, which is in accordance with a potential contribution to the airway neutrophilia elicited by intranasal (i.n.) exposure to α-GalCer, PBS-57, or LPS.
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Figure 2. NK1.1neg iNKT cells are the major iNKT subset producing
IL-17. Liver MNCs from wild-type mice were stained with CD1d/α-GalCer
tetramers, anti-TCRβ, and NK1.1 before sorting. (A) Representative FACS
profiles obtained before (left) and after (right) sorting of CD1d/α-GalCer
tetramers +NK1.1neg (NK1.1neg iNKT) and CD1d/α-GalCer tetramers
+NK1.1pos (NK1.1pos iNKT) liver iNKT cells. (B–F) Sorted NK1.1neg iNKT
and NK1.1pos iNKT liver MNCs were stimulated with α-GalCer (B–D) or
synthetic B. burgdorferi glycolipids (BbGL-II [IIc]) or GalA-GSL (GSL;
E and F) plus irradiated liver MNCs from Jα18−/− mice as APCs. Sorted
CD4+CD62L+ T cells from Jα18−/− mice were stimulated with α-GalCer
plus irradiated liver MNCs from Jα18−/− mice as APCs (G). 3 d later, IL-17
(B, E, and G), IL-4 (C and F), and IFN-γ (D) were measured in the supernatants. No cytokine was detected in the absence of α-GalCer stimulation,
in the absence of APCs or when APCs alone were stimulated with α-GalJEM

NK1.1neg and NK1.1pos iNKT cell subsets are
functionally distinct
The preferential production of IL-17 by NK1.1neg iNKT
cells raised the question of whether their NK1.1pos counterparts were unable to produce the same amount because
of the inhibition exerted by endogenous IL-4 and IFN-γ.
To address this issue, we blocked both cytokines by the
corresponding neutralizing mAbs before stimulation with
α-GalCer. Even though approximately fourfold more
IL-17 was produced by NK1.1pos cells in these conditions
(Fig. 3 A), the concentrations remained eight times lower
than those generated by the NK1.1neg subset (Fig. 3 B),
indicating that the two populations are functionally
distinct. Nonetheless, the IL-17 production by the NK1.1neg
population remained sensitive to down-regulation by IL-4
and IFN-γ, as assessed by the strong inhibitory effect of
exogenous cytokines (Fig. 3 B).
Cer (not depicted). Data represent the mean ± the SD of two to three
individual experiments. *, P < 0.05. (H) Intracellular IL-17 staining was
performed after in vitro stimulation of liver MNCs and analyzed among
gated CD1d/α-GalCer tetramers +NK1.1neg or CD1d/α-GalCer tetramers
+NK1.1pos by flow cytometry. The percentage of IL-17+ and Ig control+
cells is indicated in each graph. (I) Representative FACS profile of Vβ expression by gated NK1.1neg and NK1.1pos iNKT cells. Data (H and I) are representative of three independent experiments. nd, not detected.
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from hepatic MNCs and sorted them into two subsets according to their NK1.1 expression (Fig. 2 A). Upon stimulation
with α-GalCer, IL-17 was only detected in supernatants of
NK1.1neg iNKT cells (Fig. 2 B), along with very low amounts
of IL-4 and IFN-γ (Fig. 2, C and D). In contrast, the NK1.1pos
subset produced high levels of the latter two cytokines (Fig. 2,
C and D), but little IL-17 (Fig. 2 B), proving that it responded
normally to α-GalCer stimulation. GalA-GSL and BbGLIIc
ligands also induced IL-17 production by sorted NK1.1neg, but
not NK1.1pos, iNKT cells (Fig. 2 E). NK1.1pos iNKT cells
were activated by these ligands because they produced IL-4
(Fig. 2 F). No detectable IL-17 production was observed when
sorted T cells from Jα18−/− mice were stimulated with
α-GalCer (Fig. 2 G). The conclusion that the NK1.1neg subset
is the main source of IL-17 among iNKT cells was confirmed
by intracellular cytokine staining, as shown in Fig. 2 H.
With the exception of IL-17, which is produced by
NK1.1neg iNKT cells, and IL-4, IFN-γ, and IL-3, which are
produced more efficiently by NK1.1pos than NK1.1neg iNKT
cells, the cytokine profile generated by the two subsets in response to α-GalCer was essentially the same, as assessed by a
protein array detecting 32 different cytokines (Fig. S1, available at http://www.jem.org/cgi/content/full/jem.20061551/
DC1). Moreover, NK1.1neg and NK1.1pos iNKT cells were
undistinguishable by the expression of major iNKT cell
markers, such as CD4, CD44, CD62L, CD69, Ly49A, and
Ly49C, which occurred at similar levels (Fig. S2). Furthermore, both populations shared the Vβ bias that is typical for
NK1.1pos iNKT cells (Fig. 2 I).
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Recent studies reported that TGF-β and IL-6 are required for driving the differentiation of naive CD4 T cells
into Th17 cells (25), thus prompting us to verify whether
NK1.1pos iNKT cells become more efficient IL-17 producers
in these conditions. Fig. 3 C clearly shows that this is true for
naive conventional T cells, but not for NK1.1pos iNKT cells,
even though they retained their ability to produce both IL-4
and IFN-γ (Fig. 3, D and E), which proves responsiveness to
stimulation. In addition, we tested the effect of IL-23 on
NK1.1pos iNKT cells, knowing that it enhances IL-17 production by conventional T cells (26). Yet, once again, this
treatment did not increase IL-17 secretion by NK1.1pos iNKT
(Fig. 3 F), suggesting that NK1.1neg and NK1.1pos cells are,
indeed, functionally distinct iNKT cell subsets.
Physiological relevance of NK1.1neg iNKT and IL-17 in early
host defense to airborne antigens
Because of their constant exposure to foreign antigens, airways and lungs depend on a competent immune response
to avoid deleterious inflammatory responses caused by inefficient clearance of pathogens. Having established that iNKT
cells are potent IL-17 producers, we addressed the question
4 of 7

Figure 4. IL-17 production by lung MNCs stimulated with 𝛂-GaCer,
PBS-57, or LPS requires iNKT cells. Total (A–C) or sorted (D) NK1.1pos
iNKT and NK1.1neg iNKT cells from lung MNCs from wild-type (A–D) and
Jα18−/− (A–C) mice were stimulated in vitro with α-GalCer (A–D), PBS-57
(B), or LPS (C). 3 d later, supernatants were recovered and IL-17 was measured by ELISA. Data represent the mean ± the SEM of four individual
mice. No cytokine was detected without stimulation (not depicted).
*, P < 0.05. (E) Representative FACS profiles showing the higher percentage
of NK1.1neg iNKT cells among gated TCRβ+ iNKT cells from lung.

of their participation in airway neutrophilia resulting from
exposure to α-GalCer, PBS-57, which is another iNKT cell
ligand (27), or LPS. We first verified that pulmonary iNKT
cells could produce IL-17 upon activation, which was actually
the case for MNCs from wild-type, but not from Jα18−/−,
mice after exposure to these ligands (Fig. 4, A–C). We next
sorted NKT cells from pulmonary MNCs and found once
again that only the NK1.1neg subset responded to α-GalCer
stimulation in terms of IL-17 production (Fig. 4 D). Remarkably,
this subpopulation turned out to be much more frequent
in the lung than in the liver (Fig. 2 A) or in the spleen
(Fig. S3, available at http://www.jem.org/cgi/content/full/
jem.20061551/DC1) because it comprises up to 40% of pulmonary iNKT cells in naive mice (Fig. 4 E).
NK1.1NEG INKT CELLS PRODUCE INTERLEUKIN-17 | Michel et al.
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Figure 3. Inhibition of IL-17 production by iNKT cells in the presence of IL-4 and IFN-𝛄. (A and B) Sorted liver NK1.1pos iNKT (A and F)
and NK1.1neg iNKT (B) cells were cocultured with irradiated liver MNCs
from Jα18−/− mice as APCs and stimulated with α-GalCer in the presence
or absence of anti–IL-4 and anti–IFN-γ mAb (A) of IL-4 and IFN-γ (B), or
IL-23 (F). (C–E) Sorted NK1.1pos iNKT and naive conventional T cells were
cocultured with anti-CD3, anti-CD28, TGFβ, IL-1α, IL-6 and TNF-α. 3 d
later, IL-17 (C), IL-4 (D), and IFN-γ (E) were measured in all supernatants.
Data represent the mean ± the SD of two to three individual experiments. *, P < 0.05.
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from their NK1.1pos counterpart because of their high production of IL-17 and low secretion of IFN-γ and IL-4. The
existence of distinctive subpopulations provides a possible explanation for the contrasting effects exerted by iNKT cells. In
support of this idea, a recent report demonstrates that liver
CD4neg NKT cells are unique in their capacity to confer an
antitumor response (28). Our findings provide the first evidence for a particular NK1.1neg iNKT subset endowed with
a preferential IL-17–producing profile induced by various
antigens that we propose to name iNKT17 cells. The fact
that this phenotype is more abundant in the lung than in liver
or spleen (Fig. S3) supports the notion that specialized iNKT
cell subsets may reside in different organs.
MATERIALS AND METHODS

Cell preparation. Lymphocytes were isolated from the liver, spleen, or
lung, as previously described (15, 30).

Figure 5. 𝛂-GalCer–, PBS-57–, or LPS-induced neutrophil recruitment to airways implicates iNKT cells. (A–D) Wild-type and Jα18−/−
mice received a single i.n. dose of 10 μg LPS (A), 2 μg PBS-57 (B), or 2 μg
α-GalCer (B–D) 24 h before sacrifice. The number of neutrophils recruited
in BALF (A and B) and the concentration of IL-17 (C) is represented.
(D) Mice were treated with anti–IL-17 mAb 24 h before i.n. exposure to
α-GalCer. The number of neutrophils recruited in BALF was determined 24 h
later. The injection of control mAb did not modify neutrophil recruitment
(not depicted). Data represent the mean ± the SEM of 5–10 individual
mice. *, P < 0.05; **, P < 0.01.

NK1.1neg iNKT cells display a tissue distribution and a
capacity to produce IL-17 that is consistent with their potential role in pulmonary neutrophil recruitment. The physiological relevance of our data was also supported by the
observation that in iNKT cell–deficient Jα18−/− mice, airway neutrophilia in response to LPS instillation was significantly decreased relative to wild-type controls (Fig. 5 A).
Because in vivo treatment with LPS activates several cell
populations besides iNKT cells, we delivered α-GalCer or
PBS-57 by the same i.n. route to target iNKT cells specifically. In these conditions, neutrophilia occurred only in the
lung of wild-type, but not of Jα18−/−, mice (Fig. 5 B). Furthermore, higher IL-17 levels were observed in bronchoalveolar lavage fluid (BALF; Fig. 5 C), and the neutralization of
endogenously produced IL-17 by anti–IL-17 mAb administered before specific iNKT cell activation with α-GalCer resulted in a net decrease in airway neutrophilia (Fig. 5 D),
providing an additional argument for the role of IL-17 as an
important mediator of neutrophil recruitment.
In conclusion, our study has revealed a new iNKT subset
phenotypically characterized by the lack of the NK1.1 surface marker. NK1.1neg iNKT cells are functionally distinct
JEM

FACS analysis and sorting of iNKT cells and conventional, naive
T cells. MNCs were stained with anti-Vβ8.1/8.2 (clone MR5-2), antiVβ8.3 (clone 1B3.3), anti-Vβ7 (clone TR310; mAb provided by S. Latour
[Institut National de la Santé et de la Recherche Médicale, Paris France] and
J.C. Bories [EA3963, Paris, France]), or anti-NK1.1 (clone PK136) mAb
and CD1d/α-GalCer tetramers (plasmids containing CD1d and b2m genes
were provided by M. Kronenberg, La Jolla Institute for Allergy and Immunology, San Diego, CA). NK1.1pos iNKT (tetramerspos) and NK1.1neg iNKT
(tetramerspos) cells were then sorted. In parallel, splenocytes were stained
with anti-CD4 (clone RM4-5) and anti-CD62L (clone Mel14) antibodies
before sorting of conventional naive CD4+CD62L+ T cells. All cells were
sorted using a FACSVantage cell sorter (Becton Dickinson).
Cell culture. A final concentration of 106 liver or lung MNCs or 2.5 × 105
sorted iNKT cells per milliliter were cultured with or without irradiated
liver MNCs (5 Gy) from Jα18−/− or CD1d−/− mice as APCs, at a ratio of
1:2. Cells were cultured in RPMI 1640 medium containing antibiotics, 10%
FCS, 4 mg/ml β-mercaptoethanol, and 200 mM glutamine (all from Invitrogen) incubated at 37°C with 100 ng/ml α-GalCer solution, 100 ng/ml
PBS-57, 10 μg/ml BbGL compounds, or 1 μg/ml LPS. 10 μg/ml of blocking anti–IL-4 (clone 11B11) and/or 10 μg/ml anti–IFN-γ (clone R46A2),
as well as 1 μg/ml of coated anti-CD3 and 10 μg/ml anti-CD28 antibodies,
or their respective isotype controls, were used in some experiments. In some
conditions, exogenous cytokines, such as 4 ng/ml mouse IL-4, 10 ng/ml
IFN-γ, 1 ng/ml TGF-β, 40 ng/ml IL-1α, 5 ng/ml IL-6, 10 ng/ml IL-23,
and 20 ng/ml TNF-α (all from R&D Systems), were also added. All culture
supernatants were harvested and stored at −80°C.
Determination of cytokines. The levels of IL-17A (R&D Systems), IL-4,
and IFN-γ were assessed by ELISA, as previously described (28, 29). Cytokine protein array II was purchased from Ray Biotech and used for analyzing
supernatants from α-GalCer–stimulated sorted NK1.1pos and NK1.1neg
iNKT cells according to the manufacturer’s instructions.
Intracellular cytokine staining. Liver MNCs were stimulated for 4 h
with 10−8 M PMA (Sigma-Aldrich), 10−6 M ionomycin, and 10 μg/ml
brefeldin A. Cells were then washed and incubated with CD1d-α-GalCer
tetramer-APC, anti-NK1.1 PerCP-Cy-5.5, and anti–TCRβ-FITC. For intracellular staining, cells were fixed with 4% PFA, washed, and permeabilized
5 of 7
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Animals. 7–9-wk-old C57BL/6 mice were purchased from Janvier.
Jα18−/−–, CD1d−/−–, and IFN-γ−/−–deficient mice (29, 30) were bred in
our own facilities. All mice were kept in well-controlled animal housing facilities and had free access to tap water and pellet food. Animal experiments
were performed according to the French Institutional Committee.
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with 0.5% saponin (Sigma-Aldrich), and then further incubated with
anti–IL-17-PE or isotype control (BD Biosciences). The cells were washed
and analyzed on a FACSCalibur (Becton Dickinson) using CellQuest software (BD Biosciences).
In vivo treatment. Mice received a single i.n. administration of 2 μg α-GalCer (Kirin Brewery Co., Ltd), 2 μg PBS-57 (Sigma-Aldrich), or 10 μg LPS
(Sigma-Aldrich) 24 h before sacrifice. In some experiments, mice received
100 μg of anti–IL-17 mAb (R&D Systems) or control Ig (Sigma-Aldrich) i.p.
24 h before ligand administration. Differential cell counts were determined in
BALF 24 h after ligand instillation, as previously described (30).

8.

9.

10.

11.

Online supplemental material. Fig. S1 shows cytokine profile of NK1.1pos
and NK1.1neg liver iNKT cells stimulated with α-GalCer for 3 d. 32 different
cytokines were analyzed using mouse cytokine array II membranes. Fig. S2
shows that NK1.1neg iNKT and NK1.1pos iNKT cells express similar levels
of CD4, CD69, CD44, CD62L, Ly49A, and Ly49C markers. All antibodies
used were obtained from Becton Dickinson. Fig. S3 shows the percentage
of NK1.1pos iNKT and NK1.1neg iNKT cells among gated CD1d/α-GalCer
tetramers +TCRβ+ iNKT splenocytes.
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